We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
In T2DM requiring insulin initiation, icodec titrated with an app safely reduced HbA 1c vs. daily basal insulin analogues at 52 wk.
- Authors
Liakos, Aris; Karagiannis, Thomas; Tsapas, Apostolos
- Abstract
Source Citation: Bajaj HS, Aberle J, Davies M, et al. Once-weekly insulin icodec with dosing guide app versus once-daily basal insulin analogues in insulin-naive type 2 diabetes (ONWARDS 5): a randomized trial. Ann Intern Med. 2023;176:1476-1485. 37748181 Clinical Impact Ratings: GIM/FP/GP: Endocrinology:
- Subjects
INSULIN; TYPE 2 diabetes; BIBLIOGRAPHICAL citations; INSULIN therapy; MOBILE apps
- Publication
Annals of Internal Medicine, 2024, Vol 177, Issue 1, pJC6
- ISSN
0003-4819
- Publication type
Article
- DOI
10.7326/J23-0110